Optimal Weight Loss Institute

Optimal Weight Loss Institute in Fort Lauderdale, Florida, operates as a telehealth-focused medical weight loss clinic under the clinical direction of Bertha Osorio-Campbell, a board-certified Nurse Practitioner. The practice concentrates on evidence-based metabolic interventions for patients struggling with obesity, insulin resistance, and weight-related hormonal dysfunction. Unlike traditional diet programs, the Institute employs prescription peptide therapies and comprehensive metabolic assessments to address the underlying physiological barriers to weight loss. Patients throughout Florida access care remotely through HIPAA-compliant video consultations, eliminating geographic barriers while maintaining clinical rigor and personalized treatment protocols.

The clinic's pharmacological approach centers on two FDA-approved GLP-1 receptor agonists: semaglutide and tirzepatide. Semaglutide, administered as a once-weekly subcutaneous injection, mimics the incretin hormone GLP-1 to regulate appetite, slow gastric emptying, and improve glycemic control in patients with or without type 2 diabetes. Tirzepatide represents a dual GIP/GLP-1 receptor agonist, offering enhanced metabolic effects through its action on both incretin pathways. Osorio-Campbell prescribes these peptides as part of structured weight management programs that include dosage titration schedules, nutritional counseling, and metabolic monitoring through laboratory panels. The Institute also addresses hormonal imbalances that frequently accompany obesity, including thyroid dysfunction, cortisol dysregulation, and sex hormone imbalances that can impede weight loss progress. Each patient receives individualized peptide selection and dosing based on their metabolic profile, weight loss goals, and tolerance to treatment.

Bertha Osorio-Campbell brings dual expertise in metabolic medicine and psychiatric care to her practice, recognizing the psychological components of disordered eating and weight management. Her clinical background allows the Institute to address mood disorders, emotional eating patterns, and medication-induced weight gain within the same treatment framework. This integrated approach proves particularly valuable for patients whose weight struggles intersect with depression, anxiety, or psychotropic medication use. Osorio-Campbell's protocols include baseline psychiatric screening, ongoing mental health assessment during weight loss, and coordination with existing mental health providers when appropriate. Her training in both metabolic and psychiatric medicine enables her to safely manage peptide therapy in patients with complex medical histories, including those taking antidepressants, mood stabilizers, or antipsychotic medications that commonly contribute to weight gain.

Patients initiating care at Optimal Weight Loss Institute complete an initial telehealth consultation that includes comprehensive medical history review, current medication assessment, and discussion of previous weight loss attempts. Osorio-Campbell evaluates contraindications to peptide therapy, orders baseline metabolic labs, and establishes realistic weight loss targets based on individual health status. Following the initial visit, patients receive prescriptions sent to their preferred pharmacy, detailed injection training via video demonstration, and a structured follow-up schedule. The telehealth model allows for frequent check-ins during the critical dose-escalation phase, when side effects like nausea or gastrointestinal discomfort are most common. Patients communicate with the clinical team through a secure patient portal for questions between scheduled visits, prescription refills, and reporting of adverse effects. The Institute's protocols include monthly follow-up visits during active weight loss and quarterly maintenance visits once patients reach their goal weight.

Beyond core peptide therapy for weight management, the Fort Lauderdale clinic has expanded services to include aesthetic treatments and minor dermatologic procedures, as evidenced by patient feedback regarding botox administration and skin tag removal. This diversification allows patients to address cosmetic concerns that often accompany significant weight loss, including skin laxity and facial volume changes. The telehealth infrastructure established during the COVID-19 pandemic, when the clinic also provided testing services, now supports the practice's ability to serve patients across Florida's diverse geography. With a 5.0-star rating across 156 Google reviews, the Institute has built its reputation on measurable clinical outcomes, accessible provider communication, and individualized treatment plans that extend beyond simple calorie restriction to address the complex endocrine and psychological factors driving obesity.